✦ LIBER ✦

Changes in glucocorticoid receptor levels with serial transplantation and metastatic selection in the B16Bl6 murine melanoma

✍ Scribed by RISELY, G; SHERBET, G

Book ID: 122293346
Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 63 KB
Volume: 5
Category: Article
ISSN: 0309-1651
DOI: 10.1016/0309-1651(81)90125-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Loss of glucocorticoid receptors in B16B

Loss of glucocorticoid receptors in B16BL6 murine melanoma associated with serial transplantation, metastatic selection and altered growth properties

✍ G. P. risely; G. V. Sherbet 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 528 KB

Glucocorticoid cytosolic receptors (GR) have been studied in both a primary and in a lung selected (metastatic) series of a B16BL6 murine melanoma. In the primary series tumour there was an initial increase in GR content from 40 to 95"6 fr~ mg-i protein. GR levels then fell over the next 11 transpla

Opposite effects of TPA on G1/S transiti

Opposite effects of TPA on G1/S transition and on cell size in the low metastatic B16F1 with respect to high metastatic BL6 murine melanoma cells

✍ Caterina A.M La Porta; Danilo Porro; Roberto Comolli 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Changes in the tumorigenic and metastati

Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative

✍ M. Allegrucci; P. Fuschiotti; P. Puccetti; L. Romani; M. C. Fioretti 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 738 KB

PTK787/ZK222584, a tyrosine kinase inhib

PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo

✍ Markus Rudin; Paul M. J. McSheehy; Peter R. Allegrini; Martin Rausch; Diana Baum 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB

## Abstract Assessment of tumour vascularity may characterize malignancy as well as predict responsiveness to anti‐angiogenic therapy. Non‐invasive measurement of tumour perfusion and blood vessel permeability assessed as the transfer constant, __K__^trans^, can be provided by dynamic contrast‐enha